Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
STEERLife is a life sciences company specializing in advanced pharmaceutical processing technologies and innovative drug delivery solutions. A subsidiary of the STEER Group, the company leverages its proprietary Fractional Lobe Processor (FLP) technology to enable continuous manufacturing of complex formulations. Their core expertise lies in transforming difficult-to-process ingredients into highly effective dosage forms, such as taste-masked granules and effervescent tablets. STEERLife provides a range of services including formulation development, process engineering, and contract manufacturing for global pharmaceutical partners. By integrating advanced engineering with pharmaceutical science, the company aims to improve drug bioavailability, stability, and patient compliance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on STEERLife.